A detailed history of Philadelphia Trust CO transactions in Humacyte, Inc. stock. As of the latest transaction made, Philadelphia Trust CO holds 10,000 shares of HUMA stock, worth $46,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$46,500
Previous $48,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$7.25 - $11.6 $36,250 - $58,000
-5,000 Reduced 33.33%
10,000 $73,000
Q3 2021

Nov 15, 2021

BUY
$9.21 - $16.99 $138,150 - $254,849
15,000 New
15,000 $174,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $479M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Philadelphia Trust CO Portfolio

Follow Philadelphia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.